Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2559-2567

  Braschi, Sylvie ^a   Masson, David ^b   Rostoker, Guy ^a   Florentin, Emmanuel ^b   Athias, Anne ^b   Martin, Claude ^a   Jacotot, Bernard ^a   Gambert, Philippe ^b   Lallemant, Christian ^b   Lagrost, Laurent ^b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL DU BOCAGE   (France)

Author keywords

Hypoalbuminemia; Kidney; Lipids; Nephrosis; Triglycerides

Indexed keywords

ALBUMIN; APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; FATTY ACID; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPOALBUMINEMIA; LIPID COMPOSITION; MALE; NEPHROTIC SYNDROME; PARTICLE SIZE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SURFACE CHARGE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 17344367862     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2559     Document Type: Article

References (16)

1. Joven J, Villabona CV, Vilella E, Masaa L, Alberti R, Valles M. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med. 1990;323:579-584.
2. Appel GB, Blum CB, Chien SC, Kunis CL, Appel AS. The hyperlipidemia of the nephrotic syndrome: relation to plasma albumin concentration, oncotic pressure, and viscosity. N Engl J Med. 1985;312:1544-1548.
3. Gherardi E, Rota E, Calandra S, Genova R, Tamborino A. Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome. Eur J Clin Invest. 1977;7:563-570.
4. Warwick GL, Caslake MJ, Boulton-Jones JM, Dagen M, Packard CJ, Sheperd J. Low-density lipoprotein metabolism in the nephrotic syndrome. Metabolism. 1990;39:187-192.
5. Warwick GL, Packard CJ, Demant T, Bedford DK, Boulton-Jones JM, Sheperd J. Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria. Kidney Int. 1991;40:129-138.
6. Keilani T, Schlueter WA, Levin ML, Batlle DC. Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor. Ann Intern Med. 1993;118:246-254.
7. Kaysen GA, Gambertoglio J, Felts J, Hutchison FN. Albumin synthesis, albuminuria, and hyperlipidemia in nephrotic syndrome. Kidney Int. 1987;31:1368-1376.
8. Joven J, Simo JM, Vilella E, Camps J, Espinel E, Villbona C. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria. Clin Chem. 1995;41:908-913.
9. Garber DW, Gottlieb BA, Marsh JB, Sparks CE. Catabolism of very low density lipoproteins in experimental nephrosis. J Clin Invest. 1984;74:1375-1383.
10. Staprans I, Felts JM, Couser WG. Glycosaminoglycans and chylomicron metabolism in control and nephrotic rats. Metabolism. 1987;36:496-501.
11. Yoshino G, Hirano T, Nagata K, Maeda E, Naka Y, Murata Y, Kasumi T, Kasuga M. Hypertriglyceridemia in nephrotic rats is due to a clearance defect of plasma triglycerides: overproduction of triglyceride-rich lipoprotein is not an obligatory factor. J Lipid Res. 1993;34:875-884.
12. Levy E, Ziv E, Bar-On H, Shafrir E. Experimental nephrotic syndrome: removal and tissue distribution of chylomicrons and very-low-density lipoproteins of normal and nephrotic origins. Biochim Biophys Acta. 1990;1043:259-266.
13. Davies RW, Staprans L, Hutchison FN, Kaysen GA. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in nephrotic rats. J Clin Invest. 1990;86:600-605.
14. Marsh JB, Sparks CE. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis. J Clin Invest. 1979;64:1229-1237.
15. Davis RA, Engelhorn SC, Weinstein DB, Steinberg D. Very low density lipoprotein secretion by cultured rat hepatocytes: inhibition by albumin and other macromolecules. J Biol Chem. 1980;255:2039-2045.
16. Vega GL, Toto RD, Grundy SM. Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia. Kidney Int. 1995;47:579-586.